INS and diabetes mellitus: We hypothesized that placental drug efflux transporter expression may be altered in individuals who have diabetes, but could be normalized to levels found in healthy term controls in patients with well-managed diabetes based on our previous preclinical findings in pregnant animal models of non-treated and insulin-treated diabetes mellitus [16].